Keyword
Quick search:
Result Content Outlet Published Research
Result Content Outlet Published Research
1 Sanofi dumps Principia Biopharma's San Francisco labs with plans to immediately cut 38 jobs FierceBiotech 5 months ago
2 Sanofi's BTK inhibitor flunks phase 3 autoimmune trial, delivering blow to $3.7B biotech bet FierceBiotech 5 months ago
3 Tyrosine Protein Kinase ITK Market Report 2022 Market SWOT Analysis,Key Indicators,Forecast 2027 : Arrien Pharmaceuticals LLC, Genentech Inc, Con – The Oxford Spokesman The Oxford Spokesman 13 hours ago
4 Sanofi to acquire Principia Biopharma GlobeNewswire 1 year ago
5 Sanofi tries to quiet naysayers with follow-up data on MS drug at heart of $3.7B Principia buyout FierceBiotech 4 months ago
6 Sanofi Acquires Principia Biopharma in $3.6 Billion Deal BioSpace 1 year ago
7 Nurix Therapeutics Advances Clinical and Preclinical Pipeline and Outlines 2022 Catalysts GlobeNewswire 19 days ago
8 Former Principia CEO Tapped to Lead Esker Therapeutics BioSpace 4 months ago
9 Sanofi goes all in on Principia, paying $3.7B to take full control of late-phase MS asset FierceBiotech 1 year ago
10 Sanofi To Acquire Principia Biopharma In $3.6B Deal Contract Pharma 1 year ago
11 Sanofi starts off 'pipeline-in-a-product' rilzabrutinib in rare skin disease, but eyes bigger prize FierceBiotech 9 months ago
12 Sanofi completes Principia Biopharma Inc. acquisition GlobeNewswire 1 year ago
13 Sanofi, aiming to speed MS treatment, to acquire Principia Biopharma for $3.68 billion STAT 1 year ago
14 Novartis' BTK inhibitor steps up where other Big Pharmas have failed in autoimmune diseases FierceBiotech 4 months ago
15 Sanofi Acquiring Principia Biopharma for $3.7 Billion The Motley Fool 1 year ago
16 Sanofi to Acquire U.S. Biotech Principia Biopharma for $100 a Share TheStreet 1 year ago
17 French group Sanofi to buy U.S. firm Principia Biopharma for $3.7 billion CNBC 1 year ago
18 Lassen Therapeutics Appoints Puneet S. Arora M.D. as Chief Medical Officer Business Wire 2 months ago
19 Inside Principia Biopharma's buyout for 32% more than Sanofi's initial offer San Francisco Business Times 1 year ago
20 Sanofi has a $50B biotech buyout budget, with Principia top of the list: report FierceBiotech 2 years ago
21 Sanofi to Acquire Principia Biopharma for $3.68 Billion njbmagazine.com 1 year ago
22 Sanofi Purchases US Drugmaker Principia Biopharma for $3.7 Billion IndustryWeek 1 year ago
23 Principia Biopharma Begins U.S. IPO Effort Seeking Alpha 3 years ago
24 Principia Biopharma Announces Pricing of Initial Public Offering GlobeNewswire 3 years ago
25 Principia Biopharma seeks $86.2 million IPO San Francisco Business Times 3 years ago
26 Sanofi Said to Mull US Biotech Targets Including Principia Bloomberg 2 years ago
27 Sanofi to acquire Principia Biopharma for $3.68B BSI bureau 1 year ago
28 Sanofi to Buy Biotech Company Principia for $3.4 Billion Bloomberg 1 year ago
29 BioAge appoints Dov Goldstein as Chief Financial Officer and Ann Neale as Chief Development Officer Business Wire 2 months ago
30 Principia Biopharma Reports Third Quarter Financial Results GlobeNewswire 2 years ago
31 Sanofi in hunt for specialty drugs with $3.7 billion deal for U.S.-based Principia Reuters 1 year ago
32 Bay Area's Principia Biopharma Eyes $86 Million IPO BioSpace 3 years ago
33 Principia Biopharma: Flawed Mechanism Of Action, Weak Phase 2 Results Point To Worthless Pipeline Seeking Alpha 2 years ago
34 Principia Biopharma: Hype Over Multiple Sclerosis "Data" Is Overblown Seeking Alpha 2 years ago
35 Sanofi to acquire Principa Biopharma for $3.68 billion European Pharmaceutical Review 1 year ago
36 Sanofi hit by filing delays for key drugs, drops an early Sangamo thalassemia asset FierceBiotech 3 months ago
37 Principia Announces Positive Data from its Phase 2 Part B Trial in Pemphigus GlobeNewswire 2 years ago
38 Principia Presents Updated Positive Data of Rilzabrutinib GlobeNewswire 2 years ago
39 Sanofi Reaches $3.68B Deal to Buy Principia and Partnered MS Drug Xconomy 1 year ago
40 Prelude Therapeutics Announces Appointment of Martin Babler to its Board of Directors GlobeNewswire 6 months ago
41 End-of-Year Restructuring Means Layoffs for These Companies BioSpace 2 months ago
42 Principia Biopharma Presents Phase 1 Clinical Data from CNS GlobeNewswire 3 years ago
43 PRNB Stock Jumps On Acquisition By Bigger Partner Sanofi Investor's Business Daily 1 year ago
44 Principia Biopharma Inc.: Setting The Record Straight On BTK Inhibition Seeking Alpha 2 years ago
45 Pharma Stock Roundup: SNY to Buy Kadmon, New Approvals for AZN & MRK's Drugs Yahoo Finance 5 months ago
46 Principia Announces First Patient Dosed in Phase 2A Trial GlobeNewswire 1 year ago
47 Principia Biopharma Appoints Shao-Lee Lin, MD, Ph.D. to Board of Directors GlobeNewswire 3 years ago
48 Sanofi to acquire BTK inhibitor firm Principia for $3.7 billion Chemical & Engineering News 1 year ago
49 Biogen taps Chinese biotech InnoCare in $125M midstage MS drug pact FierceBiotech 7 months ago
50 Sahm Adrangi's Kerrisdale Capital Issues Negative Report on Principia Biopharma Inc. and Announces Conference Call Schedule PRNewswire 2 years ago
51 2021's Top Life Sciences Clusters Named in New Report BioSpace 5 months ago
52 Acceleron Investor Avoro Says Merck Deal Undervalues Biotech Bloomberg 4 months ago
53 Cell therapy biotech PlateletBio reels in $75M as it looks ahead to first clinical test MedCity News 3 months ago
54 Brutons Tyrosine Kinase (BTK) Inhibitors Pipeline Insight Report 2021 ResearchAndMarkets.com 4 months ago
55 Patient Enrollment Concluded Early in PEGASUS Phase 3 GlobeNewswire 1 year ago
56 Chutes & Ladders—Califf nominated to lead FDA again after Woodcock's lengthy interim stint FierceBiotech 2 months ago
57 Fitch Affirms Sanofi at 'A+'/Stable Fitch Ratings 8 months ago
58 Principia Announces Positive Preliminary Data of PRN1008 from its Ongoing Phase 2 Part B Trial in Pemphigus BioSpace 2 years ago
59 Movers & Shakers, May 7 | BioSpace BioSpace 9 months ago
60 Nurix Therapeutics Announces Appointment of Stefani A. Wolff as Chief Operating Officer and Executive Vice President, Product Development GlobeNewswire 7 months ago
61 Multiple sclerosis “win” makes the Principia shorts squirm Vantage 2 years ago
62 Sanofi to Develop Principia MS Candidate PRN2246 in Up-to-$805M Collaboration Genetic Engineering & Biotechnology News 4 years ago
63 Aridis Pharmaceuticals raises $26 million in Bay Area's 10th life science IPO this year, Principia Biopharma hopes to raise $86 million in No. 11 Silicon Valley Business Journal 3 years ago
64 Packaging for Stability Studies: to Outsource or Not? Pharmaceutical Technology Magazine 6 months ago
65 Karyopharm taps longtime Pfizer, Amgen vet to steer the ship; With Merck in the rearview mirror, Roger Perlmutter stakes his claim to a CEO job — and it's a surprising choice Endpoints News 9 months ago
66 Prelude Therapeutics Announces Second Quarter 2021 Financial Results and Operations Update BioSpace 6 months ago
67 Chutes & Ladders—Novartis loses 2 leaders, one to MiroBio, another to a video game company FierceBiotech 4 months ago
68 ACELYRIN Announces Appointment of Patrick Machado, JD to Board of Directors PRNewswire 8 months ago
69 Rain Therapeutics Strengthens the Board of Directors and Scientific Advisory Board with Key Appointments of Leading Industry and Research Experts Yahoo Finance 10 months ago
70 OrbiMed Names Two New General Partners Business Wire 2 months ago
71 Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update GlobeNewswire 7 months ago
72 Sanofi Ups Immunology Game With $1.4 Billion Acquisition of Kymab BioSpace 1 year ago
73 Equillium Appoints Industry Veteran, Dolca Thomas, MD as GlobeNewswire 1 year ago
74 Bruton's Tyrosine Kinase (BTK) Inhibitor Pipeline Insight Market Report 2021 ResearchAndMarkets.com 8 months ago
75 Alzheimer's drug company Actinogen raising up to $15m The Australian Financial Review 2 months ago
76 J&J strikes $6.5 billion deal for autoimmune disease specialist Momenta Reuters 1 year ago
77 How Principia, Ultragenyx, Allakos and other Bay Area drug and diagnostics companies quietly raised nearly $3B San Francisco Business Times 2 years ago
78 Harpoon Therapeutics Appoints Experienced Biotech Leader Alan Colowick, M.D., to Board of Directors GlobeNewswire 10 months ago
79 Movers & Shakers: Precigen, Amylyx, BeiGene and More | BioSpace BioSpace 10 months ago
80 Life Sciences IP Trends for 2021 Lexology 12 months ago
81 Novartis Scores Another CSU Success With Remibrutinib Scrip 4 months ago
82 Isaac Newton's hand-written revisions to Principia fetch $2.35 million New Atlas 7 months ago
83 Sanofi Executives Predict 2021 Will be 'Transformative' Year for Company BioSpace 1 year ago
84 Sanofi Maps Out R&D Expectations For 2H 2021 Scrip 6 months ago
85 SR One Completes Spin-out from GSK and Closes First Fund at $500 Million Business Wire 1 year ago
86 Drug Deal Finimize 1 year ago
87 Sanofi Considering Additional Restructuring and Up to 1,000 Job Cuts BioSpace 2 years ago
88 JPA Health: 2021 – PharmaLive PharmaLive 9 months ago
89 Despite COVID-19, BioPharma still pushed ahead with M&A in 2020 The Pharma Letter 1 year ago
90 ECTRIMS opens: Biogen therapies did not reduce COVID-19 antibody responses in MS patients BioWorld Online 4 months ago
91 Pemphigus Vulgaris Treatment Market Increasing Number of Clinical Trials to Develop New Therapies Medgadget 4 months ago
92 SR One Adds Venture Partners to Deepen Operational Expertise Business Wire 12 months ago
93 Sanofi buys Kymab for up to $1.5 bln to expand in immunotherapy Reuters 1 year ago
94 Thrombocytopenia Market to Exhibit CAGR of 4.69% for the Study Period of 2018-2030, Backed by Expected Launch of Emerging Therapies, Reports DelveInsight PRNewswire 12 months ago
95 Subacute cutaneous lupus erythematosus flare triggered by COVID‐19 vaccine Wiley 5 months ago
96 IPOs from Nio, Eventbrite, SurveyMonkey, Principia Biopharma, SutroBiopharma and Gritsone Oncology expected in coming weeks Silicon Valley Business Journal 3 years ago
97 Deciduous Therapeutics Announces Appointments to the Board, SAB, and Advisor Roles PRNewswire 3 months ago
98 Jim Wilson startup Passage Bio plugs in CFO, CMO; Tillman Gerngross nabs a COO familiar with Covid-19 fight at Pfizer as Adagio files for IPO Endpoints News 6 months ago
99 Healthcare group Sanofi offers to buy smaller peer Kiadis for 308 mln euros Reuters 1 year ago
100 Immune Thrombocytopenia Clinical Trial Analysis and Pipeline Assessment GlobeNewswire 1 year ago